September 3, 2020 10:29 AM EDTUpdated 02:34 PM

News briefing: Ionis reads out positive data for prekallikrein-targeting drug; PPD collaborates on lupus research

In a compassionate-use pilot study for hereditary angioedema (HAE), Ionis’ PKKRx and PKK-LRx were shown to reduce the rate of …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

News brief­ing: Io­n­is reads out pos­i­tive da­ta for prekallikrein-tar­get­ing drug; PPD col­lab­o­rates on lu­pus re­search